微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.11% | -67.98% | 95.37% | 35/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 1.08% | -95.19% | -92.39% | 47/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 14.2% | -35.69% | 16.97% | 7/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 12.14% | -29.13% | 84.22% | 3/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 6.59% | -10.95% | -70.62% | 4/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 22.43% | 78.58% | 1.59% | 2/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 22.08% | 146.43% | 28.9% | 1/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 17.13% | 161.53% | 131.49% | 1/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 7.4% | 836.71% | -41.08% | 4/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.56% | 153.54% | 40.18% | 17/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 8.96% | 21.41% | 36.79% | 23/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 6.55% | 154.86% | 729.11% | 18/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.79% | 2.6% | 103.37% | 55/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | -23.46% | -35.37% | -417.89% | 65/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 7.38% | 1319.23% | 187.16% | 33/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 2.57% | 507.94% | 233.77% | 54/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.77% | 178.57% | 104.44% | 58/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -17.33% | -258.06% | -3432.69% | 65/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 0.52% | -85.91% | 182.54% | 61/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | -0.63% | -139.38% | 35.71% | 60/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | -0.98% | -131.72% | 79.75% | 64/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -4.84% | -78.6% | -231.17% | 60/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 3.69% | -24.07% | 130.63% | 47/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 1.6% | -5.33% | -48.22% | 54/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 3.09% | 735.14% | 214.02% | 25/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | -2.71% | -160.9% | -155.76% | 61/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 4.86% | -22.24% | 187.57% | 45/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 1.69% | -28.09% | 356.76% | 54/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.37% | 105.56% | -91.69% | 61/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 4.45% | 111.35% | -28.8% | 56/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 6.25% | -89.3% | 165.96% | 43/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 2.35% | 114.93% | 1205.56% | 53/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 0.18% | -99.75% | 100.46% | 58/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | -39.22% | 26.66% | -167.15% | 65/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 58.41% | 260.78% | 471.09% | 1/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | -15.74% | 26.52% | -121.98% | 61/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 71.6% | 3480% | 233.88% | 1/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | -53.48% | -76.09% | -430.33% | 64/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 16.19% | 697.54% | 175.58% | 5/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | -21.42% | -1283.43% | -1171% | 56/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2% | 185.71% | 106.59% | 37/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |